German biotech company to partner with Rwanda

- Advertisement -

BERLIN (CU)_During the past week, COVID-19 vaccinations in the Africa tripled to 13 million doses as donations of vaccines increased from developed nations. However, this still remains a drop in an ocean in a region home to 1.3 billion people, of which only 2.4 per cent has been vaccinated so far. Therefore, with the aim of setting up a sustainable Coronavirus vaccine manufacturing programme in the African continent, the government officials of Rwanda and Senegal met with the top executives of German biotechnology company BioNTech. The President of the European Commission Ursula von der Leyen also participated in the meeting that was held in Berlin on Friday (27 August).  

BioNTech is well known for its recent collaboration with…

Hot this week

Fit for a Queen: Inside the V&A’s Lavish Marie Antoinette Exhibition

The Victoria & Albert Museum’s new exhibition, Marie Antoinette...

Back in the Buyer’s Market? Australia’s housing sees a sharp uptick

Australia's property market is experiencing a significant surge, not...

NZ’s Fastest Bird Just Won — But Faces Extinction

The annual New Zealand Bird of the Year competition...

The Cozy Comfort That Comes at a Cost: Wood Fires Linked to Respiratory Decline

Healthcare (Commonwealth Union) – Using a wood or coal-burning...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories

Commonwealth Union
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.